CV Sciences (CVSI) Shareholder's Equity Growth (5y) (2015 - 2026)
CV Sciences (CVSI) Shareholder's Equity Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.00% |
| Dec 31, 2025 | -33.41% |
| Sep 30, 2025 | -39.79% |
| Jun 30, 2025 | -39.36% |
| Mar 31, 2025 | -40.52% |
| Dec 31, 2024 | -42.73% |
| Sep 30, 2024 | -41.95% |
| Jun 30, 2024 | -40.73% |
| Mar 31, 2024 | -40.20% |
| Dec 31, 2023 | -37.37% |
| Sep 30, 2023 | -32.99% |
| Jun 30, 2023 | -29.11% |
| Mar 31, 2023 | -22.49% |
| Dec 31, 2022 | -15.41% |
| Sep 30, 2022 | -38.31% |
| Jun 30, 2022 | -33.19% |
| Mar 31, 2022 | -19.33% |
| Dec 31, 2021 | -23.14% |
| Sep 30, 2021 | -11.54% |
| Jun 30, 2021 | -14.49% |